Indoco Remedies

283.90

+2.35 (0.83%) tick

NSE

Buy Sell

NSE BSE

Last updated on 20 Jun 2025 02:51 PM

Open Demat account

Returns

0.28%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

2578.79

Earning Per Share

12.65

Dividend Yield

0.46%

P/E Ratio

25.97

P/B Ratio

2.34

Debt to Equity

0.39

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research. The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

Similar Companies

Cohance Lifesciences

981.4 -9.30 (-0.01%) tick

1Yr Returns

+36.81%

Wockhardt

1726.9 +39.60 (0.02%) tick

1Yr Returns

+194.62%

J.B.Chemicals & Pharma

1758 +86.30 (0.05%) tick

1Yr Returns

-7.46%

Piramal Pharma Limited

194.47 +2.44 (0.01%) tick

1Yr Returns

+23.68%

Emcure pharmaceuticals

1313.5 -12.00 (-0.01%) tick

1Yr Returns

-2.47%